USPTO serial 79290577
TIGERMED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 26, 2021
- Examiner
- CIANCI, RYAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with TIGERMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Hangzhou Tigermed Pharmaceutical technology co., LTD
CN
Other trademarks owned by Hangzhou Tigermed Pharmaceutical technology co., LTD
HANGZHOU TIGERMED CONSULTING CO., LTD.
CN
Other trademarks owned by HANGZHOU TIGERMED CONSULTING CO., LTD.
HANGZHOU TIGERMED CONSULTING CO., LTD.
CN
Other trademarks owned by HANGZHOU TIGERMED CONSULTING CO., LTD.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; pharmaceutical research services; research in the field of cosmetics, pharmaceuticals and new products; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; laboratory research services relating to pharmaceuticals; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; scientific research for medical purposes in the area of cancerous diseases; conducting clinical trials for others [scientific research]; medical research; chemical, biochemical, biological and bacteriological research and analysis; research and development services in the field of antibodies; blood analysis services; medical laboratory services; biomedical research services; testing of chemicals; computer programming in the medical field | ACTIVE | — |
| 045 | Chaperoning; online social networking services; intellectual property consultancy; licensing of software for management of intellectual property [legal services]; licensing of intellectual property rights; legal administration of licences | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hangzhou Tigermed Pharmaceutical technology co., LTD
- Other trademarks owned by HANGZHOU TIGERMED CONSULTING CO., LTD.
- Other trademarks owned by HANGZHOU TIGERMED CONSULTING CO., LTD.
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named TIGERMED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 4, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 27, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 27, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 25, 2021 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Jan 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 27, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 10, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 21, 2020 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 2, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 5, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 30, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |